Is HCA Healthcare (HCA) Stock Outpacing Its Medical Peers This Year?

Company Overview - HCA Healthcare is one of 1025 individual stocks in the Medical sector, currently holding a Zacks Rank of 2 (Buy) [2][3] - Over the past 90 days, the Zacks Consensus Estimate for HCA's full-year earnings has increased by 1.9%, indicating improved analyst sentiment [4] Performance Analysis - HCA Healthcare has achieved a year-to-date return of approximately 19%, outperforming the average gain of 6% in the Medical group [4] - In the Medical - Hospital industry, HCA Healthcare is ranked 17 and has slightly underperformed its industry, which has gained an average of 19.8% this year [6] Comparison with Peers - AnaptysBio, Inc. has outperformed the Medical sector with a year-to-date return of 57.3% and also holds a Zacks Rank of 2 (Buy) [5] - The Medical - Biomedical and Genetics industry, to which AnaptysBio belongs, is currently ranked 71 and has seen a decline of 1.1% year to date [6] Investment Consideration - Investors interested in the Medical sector may want to monitor HCA Healthcare and AnaptysBio, Inc. for their strong performance [7]